Brief: Synact Pharma Announces Additional Data From Expand P2b Clinical Trial
03/10/2023 06:07
Oct 3 (Reuters) - SynAct Pharma AB SYNACT.ST :
* SYNACT PHARMA ANNOUNCES ADDITIONAL DATA FROM THE EXPAND
P2B
CLINICAL TRIAL FURTHER SUPPORTING EFFICACY AND ACTIVITY SEEN IN
PATIENTS WITH ELEVATED CRP
Source text for Eikon: ID:nMFN7gDrqS
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026